HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.
The spectrum of emerging pediatric and neonatal diseases reflects a dynamic interface between biological evolution, environmental change, and global interconnectedness. Novel viral infections, antibiotic-resistant pathogens, and inflammatory syndromes like MIS-C linked to COVID-19 underscore the urgency for vigilance and preparedness. Congenital anomalies associated with environmental exposures and metabolic disorders linked to modern lifestyles are also on the rise. Advances in surveillance, genomics, and point-of-care diagnostics are critical to timely detection. Emerging pediatric and neonatal diseases require cross-sector collaboration in research, policy, and clinical care to ensure rapid response mechanisms. Strengthening health infrastructure and fostering innovation will be key in managing future threats to early childhood health.
